Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
07/19/2000 | EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
07/19/2000 | EP0679091B1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
07/18/2000 | US6090925 Macromolecular microparticles and methods of production and use |
07/18/2000 | US6090923 Immunoglobulin that preferentially binds a human cytotoxin; for the treatment of virus infected or tumor target cells |
07/18/2000 | US6090920 Aminoterminal propeptides of typed 1 procollagen |
07/18/2000 | US6090913 Transesterification and other conversion reactions of acid derivatives, using an amidine base |
07/18/2000 | US6090912 Multiplicity of separate solid supports with surface having suceptible linker to single species of test compound and with interior having attached non-cleavable coding molecule; for screening ligands or acceptors |
07/18/2000 | US6090789 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof |
07/18/2000 | US6090292 Device for purifying solutions containing proteins and use of the device |
07/18/2000 | US6090288 Using an anion exchanger having ligands containing a primary, secondary or tertiary amino group covalently bound to the matrix, e.g. agarose, and 2 or 3 carbons from the matrix are an hydroxyl group or amine; high elution ionic strength |
07/18/2000 | CA2087087C Molecules for iontophoretic delivery |
07/18/2000 | CA2017315C Interleukin i inhibitor |
07/18/2000 | CA2011031C Plasmodium merozoite rhoptries antigen and derivatives thereof |
07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |
07/13/2000 | WO2000040602A1 Binding molecules for human factor viii and factor viii-like proteins |
07/13/2000 | WO2000040598A1 Separation method utilizing liquid-liquid partition |
07/13/2000 | WO2000018351A3 Aglyco products and methods of use |
07/13/2000 | WO2000015653A3 Apparatus for, and method of, storing a plurality of chemical compounds |
07/13/2000 | DE19847074C1 Verfahren zum Entfernen von Lipopolysacchariden aus wäßrigen, proteinhaltigen Lösungen A method for removing lipopolysaccharides from aqueous, protein-containing solutions |
07/13/2000 | CA2356704A1 Separation method utilizing liquid-liquid partition |
07/13/2000 | CA2354599A1 Binding molecules for human factor viii and factor viii-like proteins |
07/12/2000 | EP1018516A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
07/12/2000 | EP1018365A2 Coded particles for process sequence tracking in combinatorial compound library preparation |
07/12/2000 | EP1017711A2 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
07/12/2000 | EP1017286A1 Sequential separation of whey proteins and formulations thereof |
07/12/2000 | EP0580694B1 Production of phosphopeptides from casein |
07/12/2000 | CN2387106Y Growth liquid/liquid diffusion crystallization chamber for protein crystal |
07/12/2000 | CN1259523A Immuno active polypeptide for treating psoriasis and its prepn. method |
07/11/2000 | US6087335 Administering a polypeptide isolated from coriolus versicolor as an antitumor agent |
07/11/2000 | US6087325 Peptide-lipid conjugates |
07/11/2000 | US6087186 Synthetic library of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer; for drug screening |
07/11/2000 | US6087161 Recombinant polynucleotide of promoter and sequence encoding protein with translation stop codon in open reading frame at 3' end resuling in deletion of c-terminal amino acids important for vacuolar targeting; for fungi resistant plants |
07/11/2000 | US6087148 Method of purification of cellulose from a broth solution by crystallization |
07/11/2000 | US6086849 Reagent for preparing a scintigraphic imaging agent, comprising a specific binding peptide having a radiolabel binding moiety that forms a neutral complex when bound to a radioisotope |
07/11/2000 | CA1341048C Method and compositions for making acsf and acsf antagonists |
07/06/2000 | WO2000039165A1 Serine protease inhibitor |
07/06/2000 | WO2000038743A1 Removal of biological contaminants |
07/06/2000 | WO2000038651A1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS |
07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
07/06/2000 | WO1999054784A9 Free-form nanofabrication using multi-photon excitation |
07/06/2000 | DE19858188A1 Apparatus for dissolving albumin flakes in a liquid contained in a bottle of circular cross-section. |
07/06/2000 | CA2621097A1 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
07/06/2000 | CA2356894A1 Removal of biological contaminants |
07/06/2000 | CA2356424A1 Serine protease inhibitor |
07/05/2000 | EP1016716A2 Dna encoding a growth factor specific for epithelial cells |
07/05/2000 | EP1015885A2 Purification of substances from a biological sample |
07/05/2000 | EP1015878A1 Methods for fabricating enclosed microchannel structures |
07/05/2000 | EP1015568A1 METHOD FOR THE PRODUCTION OF rDSPA Alpha1 |
07/05/2000 | EP1015479A1 Combinatorial libraries of peptidomimetic macrocycles and processes therefor |
07/05/2000 | EP1015013A1 TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES |
07/05/2000 | EP1015009A1 Attenuated vif dna immunization cassettes for genetic vaccines |
07/05/2000 | EP0577752B1 Human pf4a receptors and their use |
07/05/2000 | CN1259140A Treatment of insulin resistance with growth hormone secretagogues |
07/05/2000 | CN1054159C Separation of proteins |
07/04/2000 | US6084066 Polypetides that include conformation-constraining groups which flank a protein-protein interaction site |
07/04/2000 | US6084062 Polypeptides that bind to tissue plasminogen activator (tPA) |
07/04/2000 | US6083917 Farnesyltransferase inhibitor peptide having specified tetrapeptide sequence |
07/04/2000 | US6083910 Therapeutic uses of resolved intact or clipped native-sequence PDGF-BB dimers |
07/04/2000 | US6083723 Vector comprising regulatory nucleotide sequences and nucleic acids that code for a exogenous polypeptide |
07/04/2000 | US6083697 Chemical amplification for the synthesis of patterned arrays |
07/04/2000 | CA2082799C Process for preparing peptides |
06/29/2000 | WO2000037484A1 Process for the preparation of amino acid amides or derivatives thereof |
06/29/2000 | WO2000037156A1 Continuous method for separating substances according to molecular size |
06/29/2000 | WO2000012542A3 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties |
06/29/2000 | WO2000012506A3 Collections of compounds |
06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
06/28/2000 | EP1013662A1 Reaction products between carboxylic acid and amino acid or amino acid condensate and process for producing the same |
06/28/2000 | EP1013285A2 Urokinase-type plasminogen activator receptor |
06/28/2000 | EP1013284A2 Purified forms of dnase |
06/28/2000 | EP1012191A1 Method for obtaining high-purity vwf or factor viii/vwf complex |
06/28/2000 | EP1012178A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
06/28/2000 | EP1012165A1 Process for the preparation of n-methyl-d-phenylalanyl-n- 1- 3- (aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide |
06/28/2000 | EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
06/28/2000 | EP0915710B1 Stable radioiodine conjugates and methods for their synthesis |
06/28/2000 | EP0811058B1 A process for the preparation of factor ix from biological sources |
06/28/2000 | EP0557418B1 A beta-type transforming growth factor |
06/28/2000 | CN1257870A Process for separating and purifying heat-shock protein-polypeptide compound as antigen of tumor |
06/28/2000 | CN1053964C Immunochemical detection of in vivo advanced glycosylation endproducts |
06/28/2000 | CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition |
06/27/2000 | US6081766 Machine-learning approach to modeling biological activity for molecular design and to modeling other characteristics |
06/27/2000 | US6080844 Process for the recovery and purification of a recombinant protein from a cell |
06/22/2000 | WO2000036398A2 Method and devices for detecting optical properties, especially luminescence reactions and refraction behaviour of molecules which are directly or indirectly bound on a support |
06/22/2000 | WO2000036136A1 Metallopeptide combinatorial libraries and applications |
06/22/2000 | WO2000036133A1 Process for producing polypeptide in cell-free protein synthesis system |
06/22/2000 | WO2000036093A2 Intein-mediated cyclization of peptides |
06/22/2000 | WO2000035941A2 Combinatorial process for preparing polyamines |
06/22/2000 | WO2000035940A2 Method and devices for applying substances to a support, especially monomers for the combinatorial synthesis of molecule libraries |
06/22/2000 | WO2000035427A1 Methods for reducing the immunogenicity of proteins, tissues, or organs |
06/22/2000 | CA2355934A1 Intein mediated cyclization of peptides |
06/22/2000 | CA2355880A1 Process for preparing polyamines |
06/22/2000 | CA2354534A1 Process for producing polypeptide in cell-free protein synthesis system |
06/22/2000 | CA2353072A1 Metallopeptide combinatorial libraries and applications |
06/21/2000 | EP1010681A1 Preparation method of physiologically active compound |
06/21/2000 | EP1009757A1 Modular protein libraries and methods of preparation |
06/21/2000 | EP1009726A1 Fluorination of proteins and peptides for f-18 positron emission tomography |
06/21/2000 | EP0205564B2 Method for the production of erythropoietin |
06/21/2000 | DE19940750A1 Substrate for analysis includes microchannels with predetermined pattern of receptors deposited and immobilized under computer control by light- or liquid-induced polymerization |
06/21/2000 | DE19858892A1 Continuous chromatographic separation of matter by molecular sizes useful e.g. for separation of isomers, uses a simulated moving bed for size exclusion chromatography |